Olema Pharmaceuticals | 4:持股變動聲明-董事 Harmon Cyrus
Olema Pharmaceuticals | 4:持股變動聲明-董事 Harmon Cyrus
Olema Pharmaceuticals | 4:持股變動聲明-董事 Harmon Cyrus
Olema Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Deep Track Capital, LP(5.44%),Deep Track Biotechnology Master Fund, Ltd.(5.44%)等
Olema Pharmaceuticals | 4:持股變動聲明-高管 Zojwalla Naseem
Olema Pharmaceuticals | 4:持股變動聲明-董事 RAPPAPORT ANDREW
Olema Pharmaceuticals | 4:持股變動聲明-董事 Harmon Cyrus
Olema Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Paradigm BioCapital Advisors LP(14.3%),Paradigm BioCapital Advisors GP LLC(14.3%)等
Olema Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Cormorant Asset Management, LP(4.49%),Bihua Chen(4.49%)等
Olema Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Kynam Capital Management, LP(0%),Kynam Capital Management GP, LLC(0%)等
Olema Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Janus Henderson Group plc(1.3%)
Olema Pharmaceuticals | 4:持股變動聲明-高管 Bohen Sean
Olema Pharmaceuticals | 4:持股變動聲明-高管 Kovacs Shane William Charles
Olema Pharmaceuticals | 4:持股變動聲明-高管 Zojwalla Naseem
Olema Pharmaceuticals | 4:持股變動聲明-高管 Myles David C.
Olema Pharmaceuticals | 4:持股變動聲明-董事 Harmon Cyrus
Olema Pharmaceuticals | SC 13G:超過5%持股股東披露文件-BlackRock, Inc.(6.0%)
Olema Pharmaceuticals | 4:持股變動聲明-高管 Zojwalla Naseem
Olema Pharmaceuticals | 4:持股變動聲明-高管 Kovacs Shane William Charles
Olema Pharmaceuticals | 4:持股變動聲明-董事 Harmon Cyrus
暫無數據